Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Castelli

Showing results (141-150 of 236) with videos related to

Pageof 24
Sort By:
Epidemiologia E Psichiatria Sociale|January 19, 2000
[Cost of psychiatric patients by disability type]F Rossi, R Blaco, C Castelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytesA Mazzocchi, W J Storkus, C Traversari, et al.
The Journal of Clinical Investigation|October 1, 1996
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigenM J Maeurer, S M Gollin, D Martin, et al.
Journal of Investigational Allergology & Clinical Immunology|March 26, 2016
Genetic Analysis as a Practical Tool for Diagnosis of Hereditary Angioedema With Normal C1 Inhibitor: A Case ReportA S Moreno, L S M Maia, P B Palhas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6M J Maeurer, S M Gollin, W J Storkus, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocolsM A Player, K C Barracchini, T B Simonis, et al.
Cell Death and Differentiation|April 14, 1999
The role of 2'-5' oligoadenylate-activated ribonuclease L in apoptosisJ C Castelli, B A Hassel, A Maran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killingL Rivoltini, M Radrizzani, P Accornero, et al.
The Journal of Experimental Medicine|January 1, 1995
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytesC Castelli, W J Storkus, M J Maeurer, et al.
Genes and Immunity|December 20, 2013
Worldwide genetic variation at the 3' untranslated region of the HLA-G gene: balancing selection influencing genetic diversityA Sabbagh, P Luisi, E C Castelli, et al.
Pageof 24

Showing results (141-150 of 236) with videos related to

Sort By:
Pageof 24
Epidemiologia E Psichiatria Sociale|January 19, 2000
[Cost of psychiatric patients by disability type]F Rossi, R Blaco, C Castelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytesA Mazzocchi, W J Storkus, C Traversari, et al.
The Journal of Clinical Investigation|October 1, 1996
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigenM J Maeurer, S M Gollin, D Martin, et al.
Journal of Investigational Allergology & Clinical Immunology|March 26, 2016
Genetic Analysis as a Practical Tool for Diagnosis of Hereditary Angioedema With Normal C1 Inhibitor: A Case ReportA S Moreno, L S M Maia, P B Palhas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6M J Maeurer, S M Gollin, W J Storkus, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocolsM A Player, K C Barracchini, T B Simonis, et al.
Cell Death and Differentiation|April 14, 1999
The role of 2'-5' oligoadenylate-activated ribonuclease L in apoptosisJ C Castelli, B A Hassel, A Maran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killingL Rivoltini, M Radrizzani, P Accornero, et al.
The Journal of Experimental Medicine|January 1, 1995
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytesC Castelli, W J Storkus, M J Maeurer, et al.
Genes and Immunity|December 20, 2013
Worldwide genetic variation at the 3' untranslated region of the HLA-G gene: balancing selection influencing genetic diversityA Sabbagh, P Luisi, E C Castelli, et al.
Pageof 24